Skip to main content
Type 1 DiabetesDiagnostics and screeningChildren's healthDiagnostic test

What this study is

This study aims at quantifying the accuracy of a self-administered fingerstick based glucose tolerance test (GTT@Home) respect to the gold-standard in-clinic venous plasma measures during the oral glucose tolerance test (OGTT) across a wide range of glycemic values in people at risk for clinical type 1 diabetes (T1D) (carriers of at least one islet autoantibody) or with new onset Stage 3 T1D within 100 days from the diagnosis.

What's being tested

  • GTT@Home

    Intervention · DIAGNOSTIC TEST

    self-administered fingerstick based glucose tolerance test

Study details

Sponsor
Yale University
Conditions
Type 1 Diabetes
Enrolling
60 people
Starts
2025-08-26
Est. completion
2027-09
Record
View on ClinicalTrials.gov ↗